IXICO (LSE:IXI) Net Margin %: -28.46% (As of Mar. 2026)


What is IXICO Net Margin %?

IXICO LSE:IXI Net Margin % is -28.46% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, IXICO ranks better than 61.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. IXICO's Net Income for the six months ended in Mar. 2026 was £-1.12 Mil. IXICO's Revenue for the six months ended in Mar. 2026 was £3.95 Mil. Therefore, IXICO's net margin for the quarter that ended in Mar. 2026 was -28.46%.

The historical rank and industry rank for IXICO's Net Margin % or its related term are showing as below:

LSE:IXI' s Net Margin % Range Over the Past 10 Years
Min: -64.84   Med: -15.03   Max: 16.45
Current: -24.98

LSE:IXI's Net Margin % is ranked better than
61.14% of 947 companies
in the Biotechnology industry
Industry Median: -89.56 vs LSE:IXI: -24.98

IXICO  (LSE:IXI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

IXICO Net Margin % Related Terms

IXICO Net Margin % Historical Data

* Premium members only.

The historical data trend for IXICO's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO Net Margin % Chart

IXICO Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.45 11.94 -17.67 -34.70 -25.27

IXICO Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.67 -18.22 -29.86 -20.84 -28.46

LSE:IXI vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, IXICO's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IXICO Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IXICO's Net Margin % distribution charts can be found below:

* The bar in red indicates where IXICO's Net Margin % falls into.


IXICO Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

IXICO's Net Margin for the fiscal year that ended in Sep. 2025 is calculated as

Net Margin=Net Income (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-1.651/6.534
=-25.27 %

IXICO's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.124/3.949
=-28.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -28.46% mean?
IXICO (LSE:IXI) has a Net Margin % of -28.46% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on IXICO and its competitors. According to the industry distribution chart, IXICO ranks #368 out of 947 companies in the Biotechnology industry, placing it in the top 38.9%.
Is IXICO's Net Margin % too high?
IXICO's current Net Margin % is -28.46%. Based on the distribution chart, IXICO ranks #368 out of 947 companies in the Biotechnology industry, which is above the industry midpoint.
How does IXICO's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, IXICO ranks #368 out of 947 companies for Net Margin %. This puts IXICO in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on IXICO and its competitors. IXICO's current Net Margin % is -28.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
Based on GuruFocus' analysis, IXICO (LSE:IXI) is currently considered Fairly Valued. The stock's GF Value™ is £0.08, compared to a current price of £0.08 — trading 5.6% above its estimated fair value. The current Net Margin % is -28.46%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For IXICO (LSE:IXI), the current Net Margin % is -28.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IXICO Business Description

Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.